BetterScholar BetterScholar
8
Role
Title
Level Year L/R
🐜 Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.
34 auth. M. Yuen, S. Lim, R. Pleśniak, K. Tsuji, H. Janssen, C. Pojoga, A. Gadano, C. Popescu, T. Stepanova, T. Asselah, Gheorghe Diaconescu, H. Yim, J. Heo, E. Janczewska, Alexander Wong, ... N. Idriz, M. Imamura, G. Rizzardini, K. Takaguchi, P. Andreone, M. Arbune, J. Hou, Sung-Jae Park, A. VÒță, J. Cremer, R. Elston, Tamara Lukić, Geoff Quinn, L. Maynard, Stuart Kendrick, H. Plein, F. Campbell, M. Paff, D. Theodore
6 2022
6
🐜
🐬 Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial
K. Mari, L. Maynard, H. Eun, B. Lebreux
6 2003
6
🐬
🐬 Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats.
K. de Mari, L. Maynard, A. Sanquer, B. Lebreux, H. Eun
6 2004
6
🐬
🐬 Therapeutic Effects of Recombinant Feline Interferon-co on Feline Leukemia Virus (FeLV)-Infected and FeLV/Feline Immunodeficiency Virus (FIV)-Coinfected Symptomatic Cats
K. Mari, L. Maynard, A. Sanquer, B. Lebreux, H. Eun
6 2004
6
🐬
🐬 Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis
M. Mateo, L. Maynard, C. Vischer, P. Bianciardi, G. MirΓ³
5 2009
5
🐬
🐬 Clinical efficacy and tolerance of miltefosine in the treatment of canine leishmaniosis
V. Woerly, L. Maynard, A. Sanquer, H. Eun
5 2009
5
🐬
🦁 Comparison of two shampoos for the treatment of canine Malassezia dermatitis: a randomised controlled trial.
L. Maynard, C. Rème, S. Viaud
5 2011
5
🦁
🐬 Therapeutic efficacy of topical hydrocortisone aceponate in experimental flea-allergy dermatitis in dogs.
S. Bonneau, V. Skowronski, A. Sanquer, L. Maynard, H. Eun
4 2009
4
🐬